PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
02-May-2022 Fabrinet Announces Third Quarter Fiscal Year 2022 Financial Results Businesswire
02-May-2022 New Data Featuring NANOBIOTIX Lead Product Candidate NBTXR3 to Be Presented at the 2022 ASCO Annual Meeting Businesswire
02-May-2022 MEI Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Businesswire
02-May-2022 Fresenius Kabi Introduces New Generic for the Treatment of Multiple Myeloma Businesswire
02-May-2022 Orano Acquires INEVO to Develop Its Engineering Activities in the Healthcare, Pharmaceuticals, Fine Chemicals, Biotechnology and Cosmetics Sectors Businesswire
02-May-2022 Annual Shareholders’ Meeting SpineGuard June 8, 2022 Businesswire
02-May-2022 New 2022 Milken Institute-Harris Poll Listening Project Survey Reveals Business Optimism Despite Current Economic Climate Businesswire
02-May-2022 Qumulo Named a Leader in IDC MarketScape Worldwide Distributed Scale-Out File System 2022 Vendor Assessment Businesswire
02-May-2022 Trends in Specialty Benefit Design Report Released by Pharmaceutical Strategies Group Businesswire
02-May-2022 Amber L. Southwell, Ph.D., Awarded Sensory SentinelTM Grant by Turner Scientific Businesswire
02-May-2022 Lawson Health Research Institute Selects Cubresa’s BrainPET System to Support Neurological Research Studies Businesswire
02-May-2022 Ingenia Therapeutics & Mosaic Biosciences Present Preclinical Data on the Variants of the Bispecific Antibody IGT-427 for the Treatment of Degenerative Retinal Diseases Businesswire
02-May-2022 Voxeleron Launches iNebula™, a Cloud-Based Platform for Optimized Ophthalmic Clinical Trial Workflow Businesswire
02-May-2022 Athersys to Participate in the Bank of America Securities 2022 Global Healthcare Conference Businesswire
02-May-2022 Medidata Recognized as a Program of the Year Winner at Forrester’s B2B Summit Businesswire
02-May-2022 Innovaderm Honoured With a CRO Leadership Award Again This Year Businesswire
02-May-2022 Nicoya Completes Acquisition of LSK Technologies, Expanding Digital Platform into Molecular Testing Businesswire
02-May-2022 Therapeutic Solutions International Announces Launching of Phase III Clinical Trial for Treating COVID-19 Lung Damage Using its JadiCell™ Universal Donor Stem Cell Drug Businesswire
02-May-2022 Propanc Biopharma Purchases Pharma Grade Raw Materials for PRP Manufacture in Preparation for Phase I First-In-Human Study Businesswire
02-May-2022 Vertex Provides Updates on Phase 1/2 Clinical Trial of VX-880 for the Treatment of Type 1 Diabetes Businesswire